RAVASIO, R.; ANTONELLI, S.; MAIORINO, A.; COSTANZO, A.; LOSI, S. Cost per responder for ixekizumab and other biologic drugs approved for the treatment of moderate-to-severe plaque psoriasis in Italy. Global and Regional Health Technology Assessment, [S. l.], v. 6, n. 1, 2019. DOI: 10.33393/grhta.2019.468. Disponível em: https://journals.aboutscience.eu/index.php/grhta/article/view/468. Acesso em: 16 may. 2024.